Latest revenue
$15.0K
as of 2026-03-31
Latest net income
—
as of 2026-03-31
Net margin
—
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $5.1M
- Enterprise value
- $5.1M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $0.20
- 52-wk low
- $0.06
- Beta
- —
- Shares out
- 25.4M
5-year trend
What this company does
ITEM 1. BUSINESS Overview Bodhi Tree Biotechnology Inc. (“us,” “our,” “we,” or the “Company”) was incorporated in the State of Delaware on December 12, 2023. We are an early-stage consulting company focused on providing plant-based menu design, recipe development, and vegetarian diet consulting services. Our executive office is located in Danville, California. We believe that our menu design, recipe development, and consulting services align with increasing consumer interest in flexitarian, vegetarian, and organic lifestyles. Industry studies indicate that consumers increasingly seek healthier recipe options and sustainable dietary habits. Our strategy is to introduce the attributes of a…
AI summary unavailable — showing raw filing excerpt
Generated from BDTB's filing dated 2025-12-29
Key risks
ITEM 1A. RISK FACTORS We have limited operating history and it is difficult to evaluate our potential for business success. We have a limited history of operations. As such, we face all the risks inherent in a new business, and there can be no assurance that we will be successful and/or profitable. Our entry into the vegetarian menu and recipe design industry and our lack of a significant operating history makes it difficult to evaluate the risks and uncertainties we face. Our failure to address these risks and uncertainties could cause our business results to suffer. Because the Company is an “emerging growth company,” the Company may take advantage of certain exemptions from various…
AI summary unavailable — showing raw filing excerpt
Generated from BDTB's filing dated 2025-12-29
Profitability
Operating margin
-868.3%
Net margin
-880.4%
Return on equity
-125.6%
Return on assets
-125.6%
Leverage
Debt / equity
0.00×
100.0%Debt / assets
0.0%
100.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $15.0K | — | — | — | — |
Q4 2025 2025-12-31 | $0 | -100.0% | $-52.9K | +18.3% | — |
Q3 2025 2025-09-30 | $7.0K | — | $-11.9K | — | -170.5% |
Q2 2025 2025-06-30 | $5.0K | -66.7% | $-20.8K | -316.1% | -415.5% |
Q1 2025 2025-03-31 | $0 | — | $-52.2K | -44881.0% | — |
Q4 2024 2024-12-31 | $5.0K | — | $-64.8K | — | -1295.5% |
Q2 2024 2024-06-30 | $15.0K | — | $9.6K | — | 64.1% |
Q1 2024 2024-03-31 | — | — | $-116 | — | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Management Consulting Services · SIC 8742
Your notes
Keep private notes on BDTB — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for BDTB in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns BDTB
No institutional holdings on file for BDTB yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once BDTB's latest filing finishes processing.